uMIF was also significantly higher in patients with SLE with highly active disease (SLEDAI-2K≥10) compared with those with inactive disease (SLEDAI-2K≤4) and higher in patients with SLE with highly active disease compared with those with mildly active disease (4<SLEDAI-2K<10) with borderline significance ( table 2 ; figure 1A ).
← all excerpts
Analysis of urinary macrophage migration inhibitory factor in systemic lupus erythematosus.
1
—
—